Document is current
Any future updates will be listed below
-
Authors
Ishida, Saeko https://orcid.org/0000-0001-6005-7533
Sato, Yusuke https://orcid.org/0000-0003-0913-7815
Chosa, Keisuke
Ezawa, Eri
Yamauchi, Yuko
Oyama, Masaaki https://orcid.org/0000-0001-6478-3735
Kozuka-Hata, Hiroko https://orcid.org/0000-0002-9286-6594
Ito, Rina
Sato, Rikako
Maeki, Masatoshi
Ishikawa, Tomo-o
Yamamura, Kenichi
Takeshita, Kohei https://orcid.org/0000-0003-3469-9844
Yamaguchi, Kensuke https://orcid.org/0000-0001-8288-1240
Kochi, Yuta https://orcid.org/0000-0002-8012-5078
Hashiya, Fumitaka
Liu, Yiwei https://orcid.org/0000-0002-8072-0715
Abe, Naoko https://orcid.org/0000-0001-6062-3515
Abe, Hiroshi https://orcid.org/0000-0003-0048-3789
Sekijima, Yoshiki
Yoshimi, Kazuto https://orcid.org/0000-0001-5110-1440
Mashimo, Tomoji https://orcid.org/0000-0001-7543-7301
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP23bm1223009h0001)
- License Information
-
More Information
Article History
Received: 19 August 2024
Accepted: 6 November 2025
First Online: 5 January 2026
Competing interests
: T.M. and K. Yoshimi are the cofounder and scientific advisor of C4U Corporation, respectively. K.C. is an employee of C4U Corporation. K. Yamamura is a scientific adviser of Transgenic Group Inc. T.I. is a director of Transgenic Inc. The other authors declare no competing interests.
